US Stock MarketDetailed Quotes
AQST Aquestive Therapeutics
- 4.070
- +0.140+3.56%
Close Apr 26 16:00 ET
- 3.970
- -0.100-2.46%
Post 19:59 ET
366.17MMarket Cap-31307P/E (TTM)
4.250High3.950Low2.99MVolume4.000Open3.930Pre Close12.36MTurnover3.74%Turnover RatioLossP/E (Static)89.97MShares6.23052wk High-3.44P/B324.79MFloat Cap1.25152wk Low--Dividend TTM79.80MShs Float20.696Historical High--Div YieldTTM7.63%Amplitude0.618Historical Low4.139Avg Price1Lot Size
Aquestive Therapeutics Stock Forum
Sign in to post a comment
$Aquestive Therapeutics(AQST.US$
From AQST website
“LibervantTM
A meaningful contribution to improved patient care
The FDA has granted tentative approval of LibervantTM(diazepam buccal film). Aquestive is prepared to commercially launch Libervant, if approved for U.S. market access. Libervant is a Diazepam Buccal Film developed as an oral rescue therapy for patients with breakthrough seizures or seizure clusters.”
From AQST website
“LibervantTM
A meaningful contribution to improved patient care
The FDA has granted tentative approval of LibervantTM(diazepam buccal film). Aquestive is prepared to commercially launch Libervant, if approved for U.S. market access. Libervant is a Diazepam Buccal Film developed as an oral rescue therapy for patients with breakthrough seizures or seizure clusters.”
2
3
$Aquestive Therapeutics(AQST.US$
EARNINGS PREVIEW
Aquestive Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Aquestive Therapeutics Inc AQST.OQ AQST.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2024
The Warren New Jersey-based company is expected to report a 10.1% increase in revenue to $12.262 million from $11.13 million a year ago, according to the mean estimate from 8 analysts, based on LSEG da...
EARNINGS PREVIEW
Aquestive Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Aquestive Therapeutics Inc AQST.OQ AQST.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2024
The Warren New Jersey-based company is expected to report a 10.1% increase in revenue to $12.262 million from $11.13 million a year ago, according to the mean estimate from 8 analysts, based on LSEG da...
4
$Aquestive Therapeutics(AQST.US$ Bigger dip so I can buy more
1
Final Stretch -into 4/26 AH Approval
$Aquestive Therapeutics(AQST.US$
👉🏻Libervant for pediatric - global sales $2-300+ million per year. HUGE 💵 ** Libervant for adults - Globally is at least double that of pediatrics 500 Mil+ 👉🏻 Anaphylm - global sales $1 billion per year if not more FINALLY 👉🏻 AQST 108 (epinephrine cream) for dermatology- Multi hundred millions. ** REACAP Revenue 📈🚀🥇💯 (buyout) hummm 🤔⏰ Small market cap of $328 million is very undervalued. If you added the potential for Libervan...
👉🏻Libervant for pediatric - global sales $2-300+ million per year. HUGE 💵 ** Libervant for adults - Globally is at least double that of pediatrics 500 Mil+ 👉🏻 Anaphylm - global sales $1 billion per year if not more FINALLY 👉🏻 AQST 108 (epinephrine cream) for dermatology- Multi hundred millions. ** REACAP Revenue 📈🚀🥇💯 (buyout) hummm 🤔⏰ Small market cap of $328 million is very undervalued. If you added the potential for Libervan...
2
ApexTradez dot com 🫵🏻💥💯
$Ocular Therapeutix(OCUL.US$
BofA has OCUL BUY PT 15 see the update positively given by Dr. Dugel's who’s expertise in retinal disease drug development. solid pwrsoective meanwhile we now await the upcoming readout of the phase 1 HELIOS trial in NPDR as the next BIG catalyst for the company
***** buy the RED day Dips and win?!? join to win a free Swing Channel for (6) months only 9 slots left from the 100 offered this morning in another platform.
$Beamr Imaging(BMR.US$ Tomorrow...
BofA has OCUL BUY PT 15 see the update positively given by Dr. Dugel's who’s expertise in retinal disease drug development. solid pwrsoective meanwhile we now await the upcoming readout of the phase 1 HELIOS trial in NPDR as the next BIG catalyst for the company
***** buy the RED day Dips and win?!? join to win a free Swing Channel for (6) months only 9 slots left from the 100 offered this morning in another platform.
$Beamr Imaging(BMR.US$ Tomorrow...
1
1
FDA PDUFA Update…
🗓️ Last week’s PDUFAs:
$Supernus Pharmaceuticals(SUPN.US$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US$ & $Johnson & Johnson(JNJ.US$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US$ & $Bristol-Myers Squibb(BMY.US$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US$...
$Supernus Pharmaceuticals(SUPN.US$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US$ & $Johnson & Johnson(JNJ.US$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US$ & $Bristol-Myers Squibb(BMY.US$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US$...
11
1
PDUFA Calendar-April
The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Vanda Pharmaceuticals(VNDA.US$$Legend Biotech(LEGN.US$$Supernus Pharmaceuticals(SUPN.US$$ImmunityBio(IBRX.US$$Aquestive Therapeutics(AQST.US$$X4 Pharmaceuticals(XFOR.US$$Liquidia(LQDA.US$$Neurocrine Biosciences(NBIX.US$$Moderna(MRNA.US$$Day One Biopharmaceuticals(DAWN.US$
...
$Vanda Pharmaceuticals(VNDA.US$$Legend Biotech(LEGN.US$$Supernus Pharmaceuticals(SUPN.US$$ImmunityBio(IBRX.US$$Aquestive Therapeutics(AQST.US$$X4 Pharmaceuticals(XFOR.US$$Liquidia(LQDA.US$$Neurocrine Biosciences(NBIX.US$$Moderna(MRNA.US$$Day One Biopharmaceuticals(DAWN.US$
...
21
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
HH1000 : approved yet post market closes red. i think shorties are gonna keep it down
Jaguar8OP HH1000: Yes you have to check on DP and shorts availability. Also, people who bought this days or weeks ago, closed their position when it got approved. You can see this in the order book.
Not all FDA approval soars. It really depends on a lot of factors.
Jay Guo :
I will buy more if it dump